Abstract: Combining PCIe partial store commands along cache line boundaries, including: receiving a plurality of Peripheral Component Interface express (PCIe) packets; splitting the plurality of PCIe packets along cache line boundaries to generate a plurality of partial store commands; and combining one or more sets of partial store commands to generate one or more combined partial store commands aligned to the cache line boundaries.

Abstract: Organic light-emitting diodes as well as luminaires with such organic light-emitting diodes are specified. The luminaires may in particular be the following apparatuses, or the luminaires are part of existing apparatuses: alarm, shower cubicle, shower head, solar protection, rain protection, lamp, bed, signaling light, changing cubicle, vision protection, housing, emergency lighting, mirror, slabs, ceiling lights, radiator cladding, blinds, noise protection, umbrella, warning light.

Abstract: Provided herein are senolytic agents for selectively killing senescent cells that are associated with numerous pathologies and diseases, including age-related pathologies and diseases. As disclosed herein, senescent cell-associated diseases and disorders may be treated or prevented by administering at least one senolytic agent or pharmaceutical compositions thereof. The senescent cell-associated diseases or disorders treated or prevented by the methods described herein include, but are not limited to, cardiovascular diseases or disorders, cardiovascular diseases and disorders associated with arteriosclerosis, such as atherosclerosis, idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), osteoarthritis, inflammatory diseases or disorders, autoimmune diseases or disorders, pulmonary diseases or disorders, neurological diseases or disorders, dermatological diseases or disorders, chemotherapeutic side effects, radiotherapy side effects, metastasis and metabolic diseases.

Abstract: Provided herein are senolytic agents for selectively killing senescent cells that are associated with numerous pathologies and diseases, including age-related pathologies and diseases. As disclosed herein, senescent cell-associated diseases and disorders may be treated or prevented by administering at least one senolytic agent or pharmaceutical compositions thereof. The senescent cell-associated diseases or disorders treated or prevented by the methods described herein include, but are not limited to, cardiovascular diseases or disorders, cardiovascular diseases and disorders associated with arteriosclerosis, such as atherosclerosis, idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), osteoarthritis, inflammatory diseases or disorders, autoimmune diseases or disorders, pulmonary diseases or disorders, neurological diseases or disorders, dermatological diseases or disorders, chemotherapeutic side effects, radiotherapy side effects, metastasis and metabolic diseases.

Abstract: Provided herein are senolytic agents for selectively killing senescent cells that are associated with numerous pathologies and diseases, including age-related pathologies and diseases. As disclosed herein, senescent cell-associated diseases and disorders may be treated or prevented by administering at least one senolytic agent or pharmaceutical compositions thereof. The senescent cell-associated diseases or disorders treated or prevented by the methods described herein include, but are not limited to, cardiovascular diseases or disorders, cardiovascular diseases and disorders associated with arteriosclerosis, such as atherosclerosis, idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), osteoarthritis, inflammatory diseases or disorders, autoimmune diseases or disorders, pulmonary diseases or disorders, neurological diseases or disorders, dermatological diseases or disorders, chemotherapeutic side effects, radiotherapy side effects, metastasis and metabolic diseases.

Abstract: Provided herein are senolytic agents for selectively killing senescent cells that are associated with numerous pathologies and diseases, including age-related pathologies and diseases. As disclosed herein, senescent cell-associated diseases and disorders may be treated or prevented by administering at least one senolytic agent or pharmaceutical compositions thereof. The senescent cell-associated diseases or disorders treated or prevented by the methods described herein include, but are not limited to, cardiovascular diseases or disorders, cardiovascular diseases and disorders associated with arteriosclerosis, such as atherosclerosis, idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), osteoarthritis, inflammatory diseases or disorders, autoimmune diseases or disorders, pulmonary diseases or disorders, neurological diseases or disorders, dermatological diseases or disorders, chemotherapeutic side effects, radiotherapy side effects, metastasis and metabolic diseases.

Abstract: System, methods, and computer-readable media for determining allowed reimbursement amounts for one or more healthcare services rendered by a healthcare provider to a patient are disclosed. The allowed reimbursement amount may be determined in accordance with reimbursement model parameter(s) and/or reimbursement rule(s) associated with a reimbursement model.

Abstract: A method for displaying and distributing provided data including media and advertisements to a user of an electronic system for the management of medical documents includes establishing and operating a web-based application for viewing, storing, managing and sharing the medical documents in electronic format by an operator, providing the provided data, and selecting at least portions of the provided data based upon sponsorship by a sponsoring entity to provide selected data, the provided data being correlated to stored profile attributes of the user. The method also includes displaying and distributing the selected data, and the sponsoring entity providing compensation to the operator.

Abstract: A patient care system includes a clinician for providing the health care to the patient, an input device for signaling that the patient is initiating a current health care encounter to provide a patient-initiated encounter signal, and current patient information provided by the patient and received by the patient care system in response to the patient-initiated encounter signal. The patient care system includes an interface device in communication with the input device for providing a clinician-notification signal in response to the patient-initiated encounter signal to permit the clinician to determine that the patient has initiated the encounter, a medical records system in communication with the input device for receiving the current patient information from the patient and input devices in communication with medical records system for receiving the current patient information from a plurality of differing patients. The differing patients are disposed at a plurality of differing locations.

Abstract: A combined writing instrument and knife comprises a tubular body, a mount disposed within the body, an elongate writing element (e.g., pen or pencil) projecting in one direction from the mount, and a knife projecting in the opposite direction from the mount. The mount is displaceable in one direction to extend the writing element from one end of the body, or in the opposite direction to extend the knife from the opposite end of the body.